Decoding Youthful Biology with AI
AI-native, GPU-accelerated discovery for the next generation of regenerative biologics.
Generative Biomolecular Design for Complex Host Environments.
*
Generative Biomolecular Design for Complex Host Environments. *
High-throughput molecular synthesis engineering for advanced biotechnology and closed-loop subterranean mineral extraction.
COMPANY OVERVIEW
EonVita Biosciences is an AI-native biological engineering company utilizing a dry-lab, GPU-accelerated discovery platform to design functional peptides, metallophores, and optimized enzymes for complex host environments.
As a proud member of the NVIDIA Inception Program, EonVita leverages enterprise-grade accelerated computing to operate across two highly synergistic execution vectors:
Biomedical Regeneration: Leveraging unique perinatal reference datasets and advanced AI-driven modeling to systematically decode youthful biology, identifying critical pathways associated with healthy longevity and cellular renewal.
Subterranean Bio-Extraction: Integrating multi-modal geospatial telemetry with micro-geochemical crystal lattice profiles to computationally generate custom, metal-binding biomolecules for closed-loop, zero-emission critical element extraction.
By unifying advanced machine-learning architectures with extreme accelerated computing, EonVita streamlines precise candidate prioritization from in-silico sequence design to high-throughput physical synthesis—driving transformative breakthroughs in both human longevity and global resource independence.
CURRENT DEVELOPMENT FOCUS
The EonVita platform operates across two highly synergistic engineering pipelines, strategically designed to maximize computational throughput and accelerate real-world deployment:
Project 001: Regenerative Biomolecular Matrix
Powered by deep-learning transformers, this pipeline systematically decodes proprietary biological reference datasets derived from perinatal tissues. The computational engine identifies critical evolutionary pathways and sequence-specific functional elements directly relevant to cellular longevity, biological youthfulness, and systemic tissue renewal.
Project 002: Closed-Loop Subterranean Extraction Engine
Integrating multi-modal satellite remote sensing, 3D geophysical telemetry, and quantitative crystal lattice parameters, this pipeline computationally models complex geological formations. The generative inference architecture designs target-specific, metal-binding peptides and optimized enzymes. Once synthesized, these bio-agents execute precise, zero-emission target element extraction—including Lithium and precious metals—from complex host-rock matrices, entirely eliminating the reliance on toxic chemical leaching.
Intellectual Property & Defensibility
To secure its competitive advantage, EonVita maintains an active provisional patent portfolio safeguarding its core in-silico discovery workflows, generative molecular design architectures, and closed-loop bio-extraction methodologies.
TEAM STRUCTURE & LEADERSHIP
EonVita’s leadership team fuses elite expertise across artificial intelligence infrastructure, regenerative biology, and institutional venture development. Backed by the NVIDIA Inception Program, our founding architecture is deliberately structured to support disciplined execution, rigorous intellectual property defense, and seamless alignment with the NVIDIA enterprise ecosystem. We operate under an intentionally sequenced execution strategy: specialized computational biology and Artificial Intelligence engineering resources are dynamically deployed as the platform transitions from foundational architecture into active modeling and high-throughput candidate optimization.
Sherry H. Jiang- Co-Founder & Chief Executive Officer
Sherry H. Jiang is a prominent legal, institutional finance, and deep-technology executive operating at the absolute frontier of computational biology, industrial biotechnology, and AI-driven asset scaling. As Co-Founder and CEO of EonVita Biosciences and Principal of American West Pacific Int’l Investment Corp. (AWPIIC), she orchestrates strategic capital deployment, cross-border corporate structuring, and rigorous, compliance-driven execution. Leveraging AWPIIC’s substantial Nevada mineral concessions, she established TerraTwin Mining LLC—not only to pioneer sustainable resource development but to serve as a massive, real-world operational proving ground for EonVita's generative biotechnology.
As the principal architect of EonVita’s intellectual property
Ms. Jiang is the lead inventor of an active U.S. provisional patent portfolio safeguarding EonVita’s closed-loop subterranean bio-extraction methodologies and advanced in-silico discovery workflows. As a highly advanced practitioner within the high-performance compute ecosystem, she holds an official NVIDIA Certificate of Competency in Building Agentic AI Applications with LLMs. Under her strategic direction, EonVita is architecting workload-driven AI Factory infrastructure intelligence, integrating multi-modal biological simulations perfectly tailored for next-generation data-center compute, networking, and power optimization.
Her rigorous multidisciplinary foundation is firmly anchored in law, finance, and public policy. Currently a California State Bar Law Student enrolled in an approved Juris Doctor (J.D.) program, Ms. Jiang holds a B.A., the UCLouvain International Law MicroMasters® (LL.M. Credential), and an Honorary Doctorate of Humanities. Her formidable professional pedigree is further reinforced by advanced credentials from Harvard Law School (Contract Law), the Harvard Kennedy School (Constitutional Foundations), private MSFA-level quantitative finance instruction at the University of San Francisco (USF), and professional Investment Banking Certifications from the New York Institute of Finance (NYIF).
Charlie Zha — Technical Advisor / Prospective Chief Technology Officer
Charlie Zha is a premier Silicon Valley technology entrepreneur and enterprise data infrastructure architect with a distinguished track record of building highly scalable architectures for Fortune 100 organizations, including IBM. As a core founder of Delphix—a globally recognized enterprise data infrastructure unicorn—he pioneered foundational breakthroughs in large-scale data virtualization and agile data management layers.
In his critical technical leadership role at EonVita, Charlie architects the platform’s high-performance compute (HPC) scaling roadmap. He ensures that massive, multi-modal datasets—ranging from satellite remote sensing and geospatial telemetry to crystallographic multi-omics profiles—are rigorously structured for extreme data-throughput efficiency. His deep engineering expertise drives the orchestration of PyTorch-based, CUDA-enabled GPU clusters, ensuring seamless scalability for generative biological modeling and high-dimensional matrix simulations as EonVita transitions its proprietary in-silico intelligence models into real-world industrial execution.
Scientific Leadership
EonVita is anchored by senior scientific leadership comprising MD-PhD expertise and Principal Investigators from world-class medical school environments and premier academic research institutions. This deep intellectual lineage guides the rigorous biological interpretation of EonVita's computationally driven discovery outputs and predictive pathway structural validations.
Strategic Wet-Lab Validation Interface
To seamlessly bridge in-silico computational engineering with real-world physical verification, EonVita’s forward-looking operational pipeline is strategically positioned alongside premier advanced life sciences (ALS) testing facilities. Leveraging our CEO's active stewardship as an Operational Advisor to a specialized research laboratory—led by an elite Stanford University MD-PhD alumnus—EonVita maintains a clear institutional intent: immediately upon the completion of current physical laboratory asset testing, EonVita will deeply integrate the NVIDIA BioNeMo framework to computationally model complex micro-geochemical pathways, enzyme kinetics, and advanced bioprocessing criteria.
This advanced computational pipeline is designed to map the predictive scientific mechanisms required for selective, high-purity mineral matrix liberation and deep-element separation. By establishing this rigorous validation gate, EonVita significantly de-risks future commercial host-lab selection and accelerates cross-industry synthetic biology scale-up.
REGENERATIVE SCIENCE & COMPUTATIONAL TECHNOLOGY ALIGNMENT
EonVita is building a computationally driven regenerative discovery and bio-extraction platform, architected around rigorously defined, GPU-accelerated deep learning workflows for high-dimensional biological and mineral systems modeling. As a proud member of the NVIDIA Inception Program, EonVita maintains an explicitly NVIDIA-aligned approach to GPU-accelerated computational discovery, fully secured under a comprehensive provisional patent-pending portfolio.
Core Modeling Architecture
Graph Neural Networks (GNNs): Deployed for complex biological pathway inference and precise mineral crystal lattice mapping.
Transformer-Based Structural Embeddings: Leveraging the NVIDIA BioNeMo framework to execute advanced multi-omics embeddings for the de novo design of functional peptides.
Systems-Level Network Modeling: Executing multidimensional simulations of regenerative signaling networks and matrix-specific biochemical extraction pathways.
Data Fusion & Compute Infrastructure
Multi-Modal Data Integration: Seamless fusion of complex genomic, proteomic, and metabolic arrays with 14-channel multispectral geospatial telemetry datasets.
Advanced Feature Engineering: AI-native preprocessing pipelines engineered specifically for dual-target discovery: critical biological longevity signals and structural mineral matrices.
Hardware-Accelerated Inference: PyTorch-based model development, intrinsically powered by CUDA-enabled GPU acceleration, optimized for highly precise, stereospecific active-site docking simulations.
Distributed Training Environments: Scalable multi-GPU environments rigorously aligned with Farmonaut's structural remote sensing observations and stringent ALS laboratory analytical testing standards.
Compute Scaling & Deployment Roadmap
Phase 1: Foundational In-Silico Modeling (Patent-Pending) — Prototyping biological and mineral matrix models targeted at precise cellular renewal and highly specific element chelation.
Phase 2: High-Throughput Matrix Optimization — GPU-accelerated multi-omics optimization paired seamlessly with ALS-validated geomorphological matrix calibration.
Phase 3: Enterprise AI Factory Scaling — Distributed, multi-GPU systems-level scaling and workload-driven AI Factory infrastructure intelligence to execute the closed-loop extraction of strategic elements, including Lithium, Gold, and Silver.
EonVita’s robust computational foundation is intentionally integrated with NVIDIA’s extreme accelerated computing ecosystem—engineered to support scalable cross-domain modeling, relentless performance optimization, and enduring long-term platform growth.